Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden · Delayed Price · Currency is SEK 2.600
+0.110 (4.42%)
Jul 24, 2026, 5:23 PM CET
STO:NEWBRY Market Cap
STO:NEWBRY has a market cap or net worth of 79.03 million as of July 24, 2026. Its market cap has decreased by -3.70% in one year.
Market Cap
79.03M
Enterprise Value
64.36M
Revenue
35.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.60
ChartMarket Cap Chart
Since February 4, 2022, STO:NEWBRY's market cap has decreased from 245.97M to 79.03M, a decrease of -67.87%. That is a compound annual growth rate of -22.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 79.03M | 126.09% |
| Dec 30, 2025 | 34.96M | -59.06% |
| Dec 30, 2024 | 85.39M | 42.48% |
| Dec 29, 2023 | 59.93M | -56.08% |
| Dec 30, 2022 | 136.45M | -44.52% |
| Feb 4, 2022 | 245.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanexa AB | 678.17M |
| Dicot Pharma AB | 622.98M |
| EQL Pharma AB | 608.31M |
| Cinclus Pharma Holding AB | 555.66M |
| Orexo AB | 532.21M |
| Enzymatica AB | 456.34M |
| Moberg Pharma AB | 438.52M |
| Klaria Pharma Holding AB (publ.) | 193.83M |